These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37993175)

  • 1. Cholesterol alterations in fragile X syndrome, autism spectrum disorders and other neurodevelopmental disorders.
    Benachenhou S; Laroui A; Dionne O; Rojas D; Toupin A; Çaku A
    Int Rev Neurobiol; 2023; 173():115-139. PubMed ID: 37993175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol metabolism pathway in autism spectrum disorder: From animal models to clinical observations.
    Lin J; de Rezende VL; de Aguiar da Costa M; de Oliveira J; Gonçalves CL
    Pharmacol Biochem Behav; 2023 Feb; 223():173522. PubMed ID: 36717034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin as a Novel Interventional Candidate for Fragile X Syndrome with Autism Spectrum Disorder in Humans.
    Won J; Jin Y; Choi J; Park S; Lee TH; Lee SR; Chang KT; Hong Y
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28632163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autism Symptoms in Fragile X Syndrome.
    Niu M; Han Y; Dy ABC; Du J; Jin H; Qin J; Zhang J; Li Q; Hagerman RJ
    J Child Neurol; 2017 Sep; 32(10):903-909. PubMed ID: 28617074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass Spectrometry for the Study of Autism and Neurodevelopmental Disorders.
    Wormwood KL; Ngounou Wetie AG; Ryan JP; Darie CC; Woods AG
    Adv Exp Med Biol; 2019; 1140():477-499. PubMed ID: 31347066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential cognitive and behavioral development from 6 to 24 months in autism and fragile X syndrome.
    Mullin LJ; Rutsohn J; Gross JL; Caravella KE; Grzadzinski RL; Weisenfeld LA; Flake L; Botteron KN; Dager SR; Estes AM; Pandey J; Schultz RT; St John T; Wolff JJ; Shen MD; Piven J; Hazlett HC; Girault JB
    J Neurodev Disord; 2024 Mar; 16(1):12. PubMed ID: 38509470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overlapping Molecular Pathways Leading to Autism Spectrum Disorders, Fragile X Syndrome, and Targeted Treatments.
    Salcedo-Arellano MJ; Cabal-Herrera AM; Punatar RH; Clark CJ; Romney CA; Hagerman RJ
    Neurotherapeutics; 2021 Jan; 18(1):265-283. PubMed ID: 33215285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double Genetic Hit: Fragile X Syndrome and Partial Deletion of Protein Patched Homolog 1 Antisense as Cause of Severe Autism Spectrum Disorder.
    Saldarriaga W; Payán-Gómez C; González-Teshima LY; Rosa L; Tassone F; Hagerman RJ
    J Dev Behav Pediatr; 2020 Dec; 41(9):724-728. PubMed ID: 32947579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain Cholesterol Biosynthetic Pathway Is Altered in a Preclinical Model of Fragile X Syndrome.
    Parente M; Tonini C; Buzzelli V; Carbone E; Trezza V; Pallottini V
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brief Report: Autism Symptoms in Infants with Fragile X Syndrome.
    Roberts JE; Tonnsen BL; McCary LM; Caravella KE; Shinkareva SV
    J Autism Dev Disord; 2016 Dec; 46(12):3830-3837. PubMed ID: 27628938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiating social preference and social anxiety phenotypes in fragile X syndrome using an eye gaze analysis: a pilot study.
    Hong MP; Eckert EM; Pedapati EV; Shaffer RC; Dominick KC; Wink LK; Sweeney JA; Erickson CA
    J Neurodev Disord; 2019 Jan; 11(1):1. PubMed ID: 30665413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neurochemical basis for the treatment of autism spectrum disorders and Fragile X Syndrome.
    Hampson DR; Adusei DC; Pacey LK
    Biochem Pharmacol; 2011 May; 81(9):1078-86. PubMed ID: 21333634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensory Processing Phenotypes in Fragile X Syndrome.
    Rais M; Binder DK; Razak KA; Ethell IM
    ASN Neuro; 2018; 10():1759091418801092. PubMed ID: 30231625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of demonstratives and personal pronouns in fragile X syndrome and autism spectrum disorder.
    Friedman L; Lorang E; Sterling A
    Clin Linguist Phon; 2019; 33(5):420-436. PubMed ID: 30346853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of brain metabolism in neurodevelopmental disorders.
    Kotchetkov P; Blakeley N; Lacoste B
    Int Rev Neurobiol; 2023; 173():67-113. PubMed ID: 37993180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological and ASD phenotypes in rare genetic syndromes: A critical review of the literature.
    Bush L; Scott MN
    Clin Neuropsychol; 2022 Jul; 36(5):993-1027. PubMed ID: 34569897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebellum neuropathology and motor skill deficits in fragile X syndrome.
    Chen YS; Guo L; Han M; Zhang SM; Chen YQ; Zou J; Bai SY; Cheng GR; Zeng Y
    Int J Dev Neurosci; 2022 Nov; 82(7):557-568. PubMed ID: 35870148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal analysis of communication repair skills across three neurodevelopmental disabilities.
    Martin GE; Barstein J; Patel S; Lee M; Henry L; Losh M
    Int J Lang Commun Disord; 2020 Jan; 55(1):26-42. PubMed ID: 31538707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early gesture use in fragile X syndrome.
    Rague L; Caravella K; Tonnsen B; Klusek J; Roberts J
    J Intellect Disabil Res; 2018 Jul; 62(7):625-636. PubMed ID: 29781139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcortical Brain Development in Autism and Fragile X Syndrome: Evidence for Dynamic, Age- and Disorder-Specific Trajectories in Infancy.
    Shen MD; Swanson MR; Wolff JJ; Elison JT; Girault JB; Kim SH; Smith RG; Graves MM; Weisenfeld LAH; Flake L; MacIntyre L; Gross JL; Burrows CA; Fonov VS; Collins DL; Evans AC; Gerig G; McKinstry RC; Pandey J; St John T; Zwaigenbaum L; Estes AM; Dager SR; Schultz RT; Styner MA; Botteron KN; Hazlett HC; Piven J;
    Am J Psychiatry; 2022 Aug; 179(8):562-572. PubMed ID: 35331012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.